Long-Term Assets: The sum of all assets classified as non-current.
Rapport Therapeutics, Inc. (RAPP) had Long-Term Assets of $11.09M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-24.06M |
|
-- |
|
-- |
|
$27.11M |
|
$-27.11M |
|
$3.04M |
|
$-24.06M |
|
$-24.06M |
|
$-24.06M |
|
$-24.06M |
|
$-24.06M |
|
$-24.06M |
|
$-27.11M |
|
$-27.30M |
|
35.27M |
|
35.27M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$290.97M |
|
$3.40M |
|
|
Long-Term Assets |
$11.09M |
$302.05M |
|
$9.38M |
|
-- |
|
$6.83M |
|
$16.22M |
|
$285.84M |
|
$285.84M |
|
$285.84M |
|
36.50M |
|
| Cash Flow Statement Financials | |
$-20.24M |
|
$21.03M |
|
$0.01M |
|
$56.91M |
|
$57.71M |
|
$0.80M |
|
$4.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
31.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.42% |
|
-8.42% |
|
-7.97% |
|
-8.42% |
|
$7.83 |
|
$-0.58 |
|
$-0.57 |
|